Chrysalis Biomedical Advisors welcomed Rob Tarbox as Partner and Managing Director.

Chrysalis Biomedical Advisors provides strategy consulting services to startups, established companies, and investors. We help clients take advantage of expanding business opportunities in healthcare, life science tools, and molecular diagnostics. Unlike generalist and many boutique firms, Chrysalis brings together commercial innovators from companies that made the genomics revolution possible, during and after their rise to prominence. Chrysalis’s intuitive understanding of science, technology, customers, and markets enables clients to build and execute growth plans. At Chrysalis, we ground our work with an intuitive understanding of market dynamics, applications, technologies and how they present real opportunities for commercial growth. Traditional consulting firms often bring little domain expertise to nuanced problems, and require a formulaic approach rather than an intuitive one. At Chrysalis, we tailor our approach to enrich our customer’s understanding of critical market opportunities and deliver objective, actionable recommendations. Our principals are involved throughout the life of projects, shaping the approach, getting to what's essential and working closely and proactively with our clients. Chrysalis is happy to engage large and small clients in both project-based or hourly engagements.

Founded 2016